Effectiveness of icotinib against non-small-cell lung cancer with uncommon EGFR mutations.

被引：2
|
作者：
Zhou, Shengyu
Hu, Xingsheng
Wang, Yan
Li Junling
Zhou, Liqiang
Hao, Xuezhi
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Beijing Key Lab Clin Study Anticanc Mol Targeted, Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Beijing Key Lab Clin Study Anticanc Mol Targeted, Dept Med Oncol,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21083
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness of Icotinib on Uncommon EGFR Exon 20 Insert Mutations: A763_Y 764insFQEA in Non-Small-Cell Lung Cancer
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Chen, R.
    Guan, Y.
    Yi, X.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2396 - S2397
  • [2] Mechanisms of primary resistance to icotinib in Chinese non-small-cell lung cancer patients with EGFR uncommon mutations: A multicenter study.
    Wang, Wen Xian
    Xu, Chunwei
    Zhu, You-Cai
    Zhang, Quxia
    Chen, Yu
    Fang, Yong
    Wang, Hong
    Zhuang, Wu
    Huang, Yun-jian
    Fang, Meiyu
    Zhang, Yinbin
    Wang, Liping
    Zhang, Huibao
    Zhou, Ying
    Zheng, Yu
    Hu, Xugang
    Jiang, Weiping
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] EGFR mutations in non-small-cell lung cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Liu, Jung-Sen
    Wu, Yu-Chung
    [J]. LANCET ONCOLOGY, 2010, 11 (05): : 412 - 413
  • [4] Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
    Yamada, Yutaka
    Tamura, Tomohiro
    Yamamoto, Yusuke
    Ichimura, Hideo
    Hayashihara, Kenji
    Saito, Takefumi
    Yamada, Hideyasu
    Endo, Takeo
    Nakamura, Ryota
    Inage, Yoshihisa
    Satoh, Hiroaki
    Iguchi, Kesato
    Saito, Kazuto
    Inagaki, Masaharu
    Kikuchi, Norihiro
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Sakai, Mitsuaki
    Kamiyama, Koichi
    Shiozawa, Toshihiro
    Hizawa, Nobuyuki
    Sekine, Ikuo
    Sato, Yukio
    Funayama, Yasunori
    Miyazaki, Kunihiko
    Kodama, Takahide
    Hayashi, Shigen
    Nomura, Akihiro
    Nakamura, Hiroyuki
    Furukawa, Kinya
    Yamashita, Takaaki
    Okubo, Hatsumi
    Suzuki, Hisashi
    Kiyoshima, Moriyuki
    Kaburagi, Takayuki
    [J]. ANTICANCER RESEARCH, 2020, 40 (10) : 5757 - 5764
  • [5] Potential Usage of Afanitib in the Treatment of Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Harada, Taishi
    Yamaba, Yukiko
    Hayata, Hiroki
    Okuda, Takashi
    Kimura, Yoshishige
    Komaki, Toshiyuki
    Kagawa, Keizo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1241 - S1241
  • [6] Clinical efficacy of icotinib in patients with advanced non-small cell lung cancer harboring EGFR exon 18,20 and 21 uncommon mutations.
    Xu, Chunwei
    Wang, Wen-xian
    Fang, Meiyu
    Zhuang, Wu
    Lin, Gen
    Chen, Xiao-hui
    Zhu, You-cai
    Du, Kai-qi
    Huang, Yun-jian
    Xu, Hai-peng
    Chen, Yan-ping
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] EGFR mutations in non-small-cell lung cancer reply
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    [J]. LANCET ONCOLOGY, 2010, 11 (05): : 413 - 413
  • [8] Effectiveness of Gefitinib against Non-Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q
    Watanabe, Satoshi
    Minegishi, Yuji
    Yoshizawa, Hirohisa
    Maemondo, Makoto
    Inoue, Akira
    Sugawara, Shunichi
    Isobe, Hiroshi
    Harada, Masao
    Ishii, Yoshiki
    Gemma, Akihiko
    Hagiwara, Koichi
    Kobayashi, Kunihiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) : 189 - 194
  • [9] Efficacy and Safety of Icotinib in Advanced Non-Small-Cell Lung Cancer Patients Harboring Uncommon EGFR Mutation: a Retrospective Analysis
    Yuan, Xiaobin
    Wang, Yang
    Yang, Min
    Shen, Zhilin
    Chen, Hui
    He, Xiangbo
    Ma, Yongbin
    Ding, Lieming
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (01): : 46 - 53
  • [10] Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
    Liu, Kejun
    Jiang, Guanming
    Zhang, Ailing
    Li, Zhuanghua
    Jia, Jun
    [J]. BMC CANCER, 2020, 20 (01)
12345